Treatment with Benznidazole during the Chronic Phase of Experimental Chagas' Disease Decreases Cardiac Alterations

Chagas' disease, caused by Trypanosoma cruzi infection, is one of the main causes of death due to heart failure in Latin American countries. Benznidazole, the chemotherapeutic agent most often used for the treatment of chagasic patients, is highly toxic and has limited efficacy, especially in t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Garcia, Simone, Ramos, Carolina O., Senra, Juliana F. V., Vilas-Boas, Fabio, Rodrigues, Maurício M., Campos-de-Carvalho, Antonio C., Ribeiro-dos-Santos, Ricardo, Soares, Milena B. P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2005
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1068607/
https://ncbi.nlm.nih.gov/pubmed/15793134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.4.1521-1528.2005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados